Mobile app increased medication adherence to 81%, developer says
HAIFA, Israel — The makers of a new app say that it increased users’ medication adherence rate to more than 80%.
The MediSafe Project said Tuesday that users reported medication adherence rates of 81%, while the rate was 84.25% for patients using statins.
According to post-launch data collected over eight weeks, users of the MediSafe Project recorded taking their drugs on time at a rate 31% higher than the World Health Organization’s estimated average adherence rate of 50%. The app, launched in November 2012, is described as the first "pillbox app" that cloud syncs users’ failure to take medication on time to their friends, family and caregivers.
"Medication adherence is a persistent and elusive problem, interrupting patients’ well-being, costing health providers and insurers billions annually and causing preventable deaths," MediSafe Project CEO Omri Shor said. "MediSafe Project’s involvement of patients’ loved ones and caretakers is providing itself a breakthrough in reducing the harm that comes from medication nonadherence."
No comments found
Campaign seeks to raise awareness of inflammatory bowel disease
NEW YORK — An organization focused on inflammatory bowel disease has enlisted a star of "NYPD Blue," "Judging Amy" and "Private Practice" to raise awareness of the condition.
The Crohn’s and Colitis Foundation of America hired actress Amy Brenneman, who has ulcerative colitis, one of two diseases that collectively make up IBD; the other is Crohn’s disease. Both conditions are autoimmune diseases that cause discomfort and inflammation of the intestines and require frequent trips to the bathroom.
The CCFA also launched an ad campaign, Escape the Stall, which includes ads showing various people in restroom stalls in order to raise awareness that IBD can affect anyone.
No comments found
Use of generics would save money, study finds
WASHINGTON — A new study indicates that the public bears "unnecessary expense" when generic drugs aren’t used.
The study, published Monday in JAMA Internal Medicine, found that prescribing branded drugs when generics are available "generates unnecessary medical expenditures, the costs of which are borne by the public in the form of higher copayments, increased health insurance costs, and higher Medicare and Medicaid expenses," the authors, led by Harvard Medical School professor Eric Campbell, wrote.
"The JAMA Internal Medicine study demonstrates that we are still leaving savings on the table that could be achieved by increasing the use of generic drugs," said Ralph Neas, president and CEO of the Generic Pharmaceutical Association, an industry lobbying group. "The use of safe and effective generic versions of brandname drugs currently saves consumers and the U.S. healthcare system $1 billion every other day, a total of $192 billion in 2011. But, as significant as these savings are, there still is room for improvement, and we must realize that generics are part of the solution to sustaining affordable healthcare in America."
You and me both... it was a very interesting study by the way. Poor people shouldn't suffer like that when it comes to health.
I actually agree with this study. Some of the Doctors prescribed those expensive medicine where in there are generics available. how about those poor people who has limited money, how can they afford such expensive medicine. I hope Doctor's could be able to find solution for this, try to considers those poor family.